Same-day Wellbutrin appointment in New York

If you’re struggling with Binge Eating Disorder (BED), you may wonder whether online healthcare can provide the help you need—especially when it comes to prescription medication. The short answer is yes: telehealth has made BED treatment more accessible than ever, and legitimate online providers can legally prescribe certain medications to help manage your symptoms. But navigating the rules, understanding what’s available, and ensuring you’re getting safe, quality care takes some knowledge.

This guide breaks down everything you need to know about getting BED medication through telehealth in 2026, from federal regulations to state-specific rules, medication options, and how to find trustworthy providers.

Understanding Telehealth Rules for BED Medications

Federal Regulations: What You Need to Know

Here’s the critical thing to understand: medications commonly prescribed for Binge Eating Disorder are not controlled substances. This matters tremendously for telehealth access.

The Ryan Haight Act—a federal law from 2008—requires an in-person medical evaluation before prescribing controlled substances (like ADHD stimulants or opioids) via telemedicine. However, this law does not apply to non-controlled medications like Topamax (topiramate) or Wellbutrin (bupropion), which are frequently used off-label for BED treatment.

As of January 2026, the DEA has extended COVID-era telehealth flexibilities for controlled substances through December 31, 2026. But for the non-controlled medications used in BED treatment, there has never been a federal in-person requirement. This means providers licensed in your state can evaluate you virtually and prescribe these medications without you ever setting foot in a physical office.

State-Level Variations

While federal law sets the baseline, individual states add their own requirements. The good news: most states now permanently allow telehealth prescribing for non-controlled medications without mandating in-person visits.

Some states do have specific rules:

States with no in-person requirement:

• California, New York, Texas, Michigan, Wisconsin, Delaware, South Carolina, and Florida all allow telehealth prescribing of non-controlled medications without requiring physical exams.

States requiring periodic in-person visits:

• Alabama requires an in-person visit within 12 months if you’ve had more than 4 telehealth visits for the same condition (though this can be satisfied by any collaborating provider, not necessarily your telehealth prescriber).
• Georgia asks providers to attempt an annual in-person exam for ongoing telemedicine care.
• New Hampshire requires an in-person follow-up within 12 months for controlled substances, but not for medications like Topamax or Wellbutrin.

The takeaway: you can almost certainly start BED medication treatment entirely online, with only a few states asking for eventual in-person follow-up if treatment continues long-term.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Medications Available for BED via Telehealth

Topamax (Topiramate)

What it is: Topiramate is an anticonvulsant medication FDA-approved for seizures and migraine prevention. It’s frequently prescribed off-label for Binge Eating Disorder because research shows it may help reduce binge frequency and support weight management.

Telehealth availability: ✅ Fully available—this is not a controlled substance, so all 50 states allow telehealth prescribing.

Typical approach:

• Providers usually start with a low dose (25mg) and gradually increase to minimize side effects
• Treatment may continue for several months or longer
• 90-day supplies with refills are common

Important considerations:

• Pregnancy risk: Topiramate is linked to birth defects, particularly cleft palate. If you’re pregnant, planning pregnancy, or not using effective contraception, your provider will discuss alternatives.
• Tapering required: Don’t stop abruptly—seizure risk exists even in people without epilepsy
• Side effects to monitor: Cognitive effects (‘foggy thinking’), tingling sensations, and metabolic changes

Who shouldn’t take it:

• Anyone pregnant or trying to conceive without contraception
• People with a history of kidney stones (increases risk)
• Those with certain metabolic conditions

Wellbutrin (Bupropion)

What it is: Bupropion is an atypical antidepressant FDA-approved for depression and smoking cessation. Studies suggest it may help reduce binge eating episodes, likely through its effects on dopamine and norepinephrine.

Telehealth availability: ✅ Fully available—not a controlled substance, legally prescribed via telehealth nationwide.

Typical approach:

• Often started at 150mg extended-release, may increase to 300mg
• Takes several weeks to see effects on binge eating
• Can be prescribed in 90-day supplies

Important considerations:

• BLACK BOX WARNING: Like all antidepressants, carries a risk of increased suicidal thoughts in people under 25—close monitoring required, especially when starting
• Contraindicated in eating disorders with purging: The FDA label explicitly warns against use in people with current or prior anorexia or bulimia due to increased seizure risk
• Seizure risk: Also contraindicated if you have a seizure disorder or are at high risk (heavy alcohol use, abrupt benzodiazepine discontinuation)
• Blood pressure: Can raise BP, especially if combined with stimulants

Who shouldn’t take it:

• Anyone with current or recent bulimia or anorexia nervosa
• People with seizure disorders
• Those taking MAO inhibitors or certain other medications
• Heavy alcohol users (increases seizure risk)

What About Vyvanse?

Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for BED. However, it’s a Schedule II controlled substance (an amphetamine-based stimulant), which makes telehealth prescribing significantly more complicated.

Most legitimate telehealth platforms do not prescribe Vyvanse or other controlled substances for BED due to:

• Stricter DEA regulations (even with current extensions)
• Higher abuse potential requiring more intensive monitoring
• State-specific restrictions on telehealth controlled-substance prescribing

If your provider determines you need Vyvanse, they’ll typically refer you for in-person evaluation with a specialist. This isn’t a limitation of telehealth quality—it’s a regulatory reality designed to prevent misuse.

Who Can Prescribe BED Medications via Telehealth?

Physicians (MDs and DOs)

All licensed physicians can prescribe these medications via telehealth in any state where they hold an active license. This is straightforward and universally accepted.

Nurse Practitioners (NPs)

The ability of NPs to prescribe independently varies significantly by state:

Full Practice Authority states (34 + DC): NPs can evaluate, diagnose, and prescribe without physician oversight. Recent additions include:

• Wisconsin (August 2025)
• Michigan (2025)
• Louisiana and Kansas (2023-2024)
• California (phased implementation 2023-2024 under AB 890)

In these states, an NP working for a telehealth platform can provide complete BED care independently.

Collaborative/Reduced Practice states: NPs can prescribe but must have a formal agreement with a supervising physician. This includes:

• Texas: NPs prescribe under a ‘prescriptive authority agreement’
• Florida: Physician collaboration required
• Georgia: Written protocol required
• Alabama: Collaborative practice mandatory

What this means for you: In collaborative states, you might see both an NP and a supervising physician’s name on documentation, but the NP typically provides your direct care. The physician oversight happens behind the scenes and usually doesn’t affect your experience.

Physician Assistants (PAs)

PAs can prescribe these non-controlled medications in all states, but like NPs in some states, they work under physician supervision. The level of autonomy varies by state, but for non-controlled BED medications, PAs at reputable telehealth services can provide effective treatment.

The Telehealth Evaluation Process

What to Expect During Your Initial Visit

A legitimate telehealth evaluation for BED should be thorough and comprehensive—typically 30-45 minutes for an initial consultation. Here’s what quality providers will cover:

Clinical assessment:

• Detailed questions about your eating patterns, including frequency and nature of binge episodes
• Verification that you meet DSM-5 diagnostic criteria for BED (recurrent binge eating episodes at least once weekly for 3 months, with feelings of loss of control and marked distress)
• Screen for other eating disorders (bulimia, anorexia) which would change treatment approach
• Mental health history, including depression, anxiety, and prior eating disorder treatment

Medical screening:

• Current medications and supplements
• Medical conditions (especially seizure disorders, cardiovascular issues, kidney problems)
• Pregnancy status and contraception (critical for topiramate)
• Substance use history (alcohol, drugs)
• Prior adverse reactions to medications

Safety protocols:

• Identity and location verification (required in many states)
• Confirmation that the provider is licensed in your state
• Discussion of telehealth limitations and when in-person care might be needed

Treatment planning:

• Explanation of medication options, including off-label use
• Discussion of therapy and other non-medication interventions
• Informed consent process
• Setting realistic expectations about timeline and outcomes

Red Flags to Watch For

Run away from services that:

• Promise a prescription before completing a thorough evaluation
• Only ask a few checkbox questions and issue medication in 5-10 minutes
• Don’t discuss therapy or lifestyle interventions
• Pressure you to start medication immediately
• Don’t explain off-label use or medication risks
• Offer to sell you medication directly rather than sending prescriptions to a licensed pharmacy

Quality indicators:

• Provider asks detailed, probing questions about your symptoms
• Discusses multiple treatment options, not just medication
• Explains why they’re recommending a particular medication
• Schedules specific follow-up appointments
• Provides clear contact information for questions or concerns
• Uses a licensed pharmacy for prescriptions
• Documents everything in a secure electronic health record

Understanding Off-Label Prescribing

You might feel uncertain when your provider suggests Topamax or Wellbutrin ‘for binge eating’ when you know these drugs are officially approved for other conditions. This is called off-label prescribing, and it’s completely legal, ethical, and extremely common in medicine.

Why Off-Label Prescribing Happens

The FDA approves medications for specific conditions based on clinical trials submitted by pharmaceutical companies. However, once approved, physicians can prescribe medications for any condition if they have clinical evidence supporting that use.

For BED specifically:

• Vyvanse is the only FDA-approved medication, but it’s a controlled stimulant with access limitations
• Clinical research supports using topiramate and bupropion for BED, even though manufacturers never sought formal FDA approval for this indication
• Medical guidelines from professional organizations recognize these as legitimate treatment options

What Your Provider Should Do

A responsible provider prescribing off-label will:

• Explain that the medication isn’t FDA-approved for BED specifically
• Describe the research evidence supporting its use
• Discuss alternative options
• Obtain your informed consent
• Document the rationale in your medical record

This transparency is standard practice and actually indicates a provider who’s following proper protocols.

Safety and Quality Assurance

The Telehealth Accountability Movement

Following some high-profile cases of problematic online prescribing (particularly involving ADHD stimulants), the telehealth industry has faced increased scrutiny. This is ultimately good news for patients because it’s led to stronger safeguards.

What changed after regulatory attention:

• Platforms implemented more rigorous provider training
• Clinical protocols became more standardized
• Documentation requirements increased
• Quality assurance monitoring expanded
• State medical boards increased oversight

How to Verify Provider Quality

Check licensure:

• Verify your provider is licensed in your state (not just any state)
• Look up their license status on your state medical or nursing board website
• Confirm no disciplinary actions or restrictions

Evaluate the platform:

• Read independent reviews (not just testimonials on the company site)
• Look for transparent pricing and clear policies
• Check if they accept insurance (if applicable to you)
• Review their privacy policy and data security measures
• Confirm they use licensed pharmacies

Klarity Health approach:At Klarity Health, we address these quality concerns through provider availability across all 50 states, transparent pricing (both insurance and cash-pay options accepted), and thorough clinical protocols that prioritize patient safety. Our providers conduct comprehensive evaluations and maintain ongoing care relationships, not one-time prescription services.

Practical Considerations

Prescription Monitoring Programs (PMPs)

Many states require providers to check prescription monitoring databases before prescribing controlled substances. Since Topamax and Wellbutrin aren’t controlled, these mandatory checks don’t apply.

However, responsible providers may still review:

• Your medication history to check for potential interactions
• Whether you’re receiving similar medications from another provider
• Any concerning patterns that might indicate you need different care

This is good clinical practice, not a sign of mistrust.

Follow-Up Care and Refills

Initial monitoring:

• Expect a follow-up within 2-4 weeks when starting medication
• Providers need to assess side effects and effectiveness
• Dose adjustments often happen in the first few months

Ongoing care:

• Monthly or bimonthly check-ins are typical
• Some states (Alabama, Georgia) require annual in-person visits for continued telehealth care
• Refills can often be authorized for 90 days or longer since these aren’t controlled substances

Insurance Coverage

Telehealth visits for mental health and psychiatric care are widely covered post-pandemic, but coverage specifics vary:

What’s usually covered:

• Initial evaluation and diagnosis
• Follow-up medication management visits
• Many plans cover medications like topiramate and bupropion (though formulary varies)

What to check:

• Whether your plan requires in-network providers
• Copay amounts for telehealth vs. in-person visits (often the same now)
• Prior authorization requirements for certain medications
• Mental health visit limits (though parity laws have reduced these)

Cash-pay options:Many telehealth platforms, including Klarity Health, offer transparent cash pricing for those without insurance or who prefer not to use it. This can sometimes be more affordable than high deductibles or copays.

Who Should NOT Use Telehealth for BED Treatment

Telehealth is powerful and accessible, but it’s not appropriate for everyone. You should seek in-person care if:

Medical complexity:

• You have severe, unstable medical conditions requiring hands-on examination
• Your binge eating has caused urgent health complications
• You need medications that can’t be prescribed via telehealth (like controlled substances in certain states)

Clinical contraindications:

• Active or recent anorexia or bulimia (particularly if considering bupropion)
• Uncontrolled seizure disorder
• Pregnancy or planning pregnancy (especially for topiramate)
• Severe substance use disorder requiring intensive treatment

Safety concerns:

• Active suicidal ideation requiring crisis intervention
• Need for higher level of care (partial hospitalization, residential treatment)
• Severe malnutrition or medical instability from eating behaviors

Preference for comprehensive team:

• You want coordinated care with a dietitian, therapist, and physician meeting together
• Your situation requires frequent vital sign monitoring or lab work
• You simply feel more comfortable with in-person care

Reputable telehealth providers will screen for these situations and refer you appropriately. A provider who pushes medication despite red flags is not acting in your best interest.

The Role of Therapy in BED Treatment

While this guide focuses on medication access, it’s crucial to understand that medication alone is rarely sufficient for Binge Eating Disorder.

Evidence-Based Psychotherapy

The gold standard treatments for BED include:

Cognitive Behavioral Therapy (CBT):

• Specifically CBT-E (Enhanced) has the strongest research support
• Addresses thought patterns that trigger binge eating
• Teaches behavioral strategies for managing urges
• Often delivered in 20 weekly sessions

Interpersonal Psychotherapy (IPT):

• Focuses on relationship patterns and emotional triggers
• Can be as effective as CBT for some people
• Particularly helpful if interpersonal stress drives binge eating

Dialectical Behavior Therapy (DBT):

• Skills-based approach for emotion regulation
• Helpful for people with intense emotional dysregulation
• Often includes mindfulness and distress tolerance techniques

Combining Medication and Therapy

Research suggests the combination of medication and therapy may be more effective than either alone. A quality telehealth provider should:

• Discuss therapy as a primary or complementary treatment
• Offer referrals to therapists (many platforms have in-house options)
• Coordinate care if you’re seeing separate providers
• Not position medication as a standalone solution

If a provider only offers medication without mentioning therapy, consider that a warning sign.

State-by-State Snapshot

Here’s a quick reference for key states (as of early 2026):

California: No in-person requirement for non-controlled meds; NP full practice authority; async telehealth allowed if meeting standard of care.

New York: No in-person for non-controlled meds (new controlled-substance rules don’t affect BED medications); NP independence after supervised hours.

Texas: No in-person requirement; NP/PA practice under physician agreement; most telehealth permitted.

Florida: No in-person for non-controlled; NP requires physician supervision; telehealth restrictions mainly apply to Schedule II.

Alabama: In-person visit within 12 months if more than 4 telehealth visits for same condition; NP collaborative practice.

Georgia: Annual in-person attempt required for ongoing telehealth; NP requires physician collaboration.

New Hampshire: No in-person for non-controlled; in-person within 12 months for controlled substances only; NP full practice authority.

Michigan: No in-person requirement; NP full practice authority as of 2025.

Wisconsin: No in-person requirement; NP independence granted August 2025.

For comprehensive, up-to-date state information, consult your provider or check the Center for Connected Health Policy database.

Looking Ahead: Regulatory Developments

What’s Changing in 2026

Federal level:

• DEA telehealth flexibilities for controlled substances extended through December 31, 2026
• Final permanent rules on telehealth controlled-substance prescribing expected by end of 2026
• No changes expected for non-controlled medications like those used in BED

State level:

• Several states considering expanding NP/PA scope of practice
• Alabama and South Carolina have pending legislation for NP independence (not yet enacted)
• Ongoing updates to telehealth parity laws for insurance coverage

What this means for you:Access to BED medications via telehealth is stable and likely to expand, not contract. The regulatory focus remains on controlled substances, preserving and even improving access to non-controlled options.

Finding the Right Telehealth Provider

Questions to Ask

Before committing to a telehealth platform:

About credentials:

• ‘Are your providers licensed in my state?’
• ‘What are the qualifications of providers who will treat BED?’
• ‘Will I see the same provider for follow-ups?’

About the process:

• ‘How long is the initial evaluation?’
• ‘What happens if medication isn’t appropriate for me?’
• ‘Do you offer therapy or just medication management?’
• ‘How do I contact my provider between appointments?’

About costs:

• ‘Do you accept my insurance?’
• ‘What’s the cash price if I don’t use insurance?’
• ‘Are there additional fees beyond the visit cost?’
• ‘What does medication cost, and where do you send prescriptions?’

About safety:

• ‘What screening do you do before prescribing?’
• ‘How do you handle side effects or emergencies?’
• ‘When would you refer me for in-person care?’

Why Klarity Health

Klarity Health offers BED treatment that addresses the key concerns of safety, accessibility, and quality:

Provider accessibility: Licensed providers available in all 50 states, ensuring you can receive care regardless of location.

Flexible payment: Accept both insurance and cash-pay, with transparent pricing so you know costs upfront.

Comprehensive approach: Providers who understand that medication is one tool in a broader treatment plan, with connections to therapy and other support.

Ongoing relationships: Not a one-time prescription service—we build continuous care relationships with regular follow-up.

Taking the Next Step

If you’re struggling with Binge Eating Disorder, telehealth can provide legitimate, safe, and effective access to professional care and medication when appropriate. The key is choosing a reputable provider and understanding what quality care should look like.

Start by:

1. Researching your options: Look for established telehealth platforms with clear credentials and transparent practices.

2. Checking your state’s rules: While most allow telehealth prescribing, knowing your state’s specific requirements helps set expectations.

3. Preparing for your evaluation: Write down your symptoms, eating patterns, medical history, and questions—thorough information leads to better care.

4. Being honest: Telehealth only works if you provide complete and accurate information about your symptoms, history, and current situation.

5. Following through: Medication requires ongoing monitoring and follow-up—commit to the appointments and communication your provider schedules.

6. Considering therapy: Look into evidence-based therapy options to complement any medication treatment.

Binge Eating Disorder is a treatable condition, and telehealth has made expert care more accessible than ever. With the right provider and realistic expectations, you can take meaningful steps toward recovery from the comfort of your home.

Ready to get started? Klarity Health offers comprehensive BED evaluations with licensed providers who can determine whether medication might help as part of your treatment plan. Visit our website to schedule your confidential consultation today.

Research Currency Statement

Verified as of: January 4, 2026

Federal Regulations

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

State-Level Verification

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

Source Quality

• Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

Areas Flagged for Monitoring

• ⚠️ Alabama and South Carolina: NP scope changes (legislation discussed in 2025 but final status unclear—assume no full independence yet pending confirmation)
• Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026)
• Verify any temporary state waivers for expiration/extension beyond 2025

Top Citations

1. HHS Press Room – DEA Telemedicine Extension 2026: Official announcement confirming extension of COVID-19 telehealth prescribing flexibilities through December 31, 2026. www.hhs.gov

2. Sheppard Mullin Health Law Blog – Telehealth and In-Person Visits: Tracking Federal and State Updates (August 2025): Comprehensive legal analysis of state-by-state telehealth prescribing changes with citations to state statutes. www.sheppardhealthlaw.com

3. Center for Connected Health Policy – Online Prescribing Database (Updated November-December 2025): Authoritative aggregation of state telehealth laws with direct quotes from state regulations. www.cchpca.org

4. Health Jobs Nationwide Blog – State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025): Industry analysis of NP scope of practice trends across states with references to legislation. blog.healthjobsnationwide.com

5. DailyMed (NIH) – Bupropion Hydrochloride Label: Official FDA-approved prescribing information including contraindications, warnings, and black box warnings. dailymed.nlm.nih.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12